Page 9 of 15
The Journal of Organic Chemistry
Hz, 1H), 4.62 (d, J = 4.4 Hz, 2H), 4.46 (s, 1H), 3.94 (d, J = 1.9 tert-Butyl
benzyl(2-(2-(hydroxymethyl)-3-(2-methylal-
Hz, 2H), 3.48 (s, 2H), 1.80 (s, 3H). 13C{1H} NMR (100 MHz,
CDCl3) δ 146.7, 139.1, 138.7, 138.4, 136.9, 134.3, 133.1,
129.2, 128.8, 128.1, 127.8, 126.9, 114.3, 111.3, 58.6, 41.3,
38.0, 22.6. IR (neat) cm-1 3343, 3073, 2920, 2852, 1626,
1492, 1395, 1098, 1010, 895, 834; HRMS (ESI-TOF) m/z:
(M+Na)+ calcd for C20H21ClONa 335.1173, found 335.1180.
(2-(2-Methylallyl)-6-(2-(p-tolyl)allyl)phenyl)methanol
lyl)benzyl)allyl)carbamate (3k): Using the same procedure
as that used for 3a afforded 3k (27 mg, 62% yield) as a col-
orless liquid. 1H NMR (400 MHz, CDCl3) δ 7.29 (q, J = 8.8, 8.0
Hz, 3H), 7.18 (d, J = 8.1 Hz, 3H), 7.05 (m, 2H), 4.92 (m, 1H),
4.81 (s, 1H), 4.71 (m, 1H), 4.58 (s, 2H), 4.42 (m, 2H), 3.76 (s,
2H), 3.44 (m, 4H), 1.79 (s, 3H), 1.43 (s, 9H). 13C{1H} NMR
(100 MHz, CDCl3) δ 155.9, 146.5, 145.6, 144.9, 138.0, 137.6,
130.5, 129.4, 128.8, 128.4, 127.9, 127.4, 127.2, 113.4, 111.6,
80.2, 77.2, 58.6, 50.6, 41.4, 37.7, 28.3, 22.9. IR (neat) cm-1
3433, 3068, 2974, 2925, 1691, 1674, 1453, 1246, 1163,
1003, 889, 766; HRMS (ESI-TOF) m/z: (M+Na)+ calcd for
C27H35NO3Na 444.2509; found 444.2512.
(2-(2-(Chloromethyl)allyl)-6-(2-methylallyl)phenyl)meth-
anol (3l): Using the same procedure as that used for 3a af-
forded 3l (13 mg, 52% yield) as a colorless liquid. 1H NMR
(400 MHz, CDCl3) δ 7.21 (t, J = 7.5 Hz, 1H), 7.10 (t, J = 7.4 Hz,
2H), 5.20 (s, 1H), 4.82 (s, 1H), 4.72 (s, 1H), 4.61 (s, 2H), 4.45
(s, 1H), 4.04 (s, 2H), 3.65 (s, 2H), 3.46 (s, 2H), 1.77 (s, 3H).
13C{1H} NMR (100 MHz, CDCl3) δ 145.9, 144.6, 138.3, 136.8,
136.5, 128.7, 128.3, 127.2, 115.2, 110.6, 57.5, 47.0, 40.6,
35.7, 21.9. IR (neat) cm-1 3346, 2923, 1648, 1443, 1276,
1261, 998, 893, 843; HRMS (ESI-TOF) m/z: (M+Na)+ calcd
for C15H19ClONa 273.1017; found 273.1025.
1
2
3
4
5
6
7
8
(3g): Using the same procedure as that used for 3a afforded
1
3g (15 mg, 51% yield) as a colorless liquid. H NMR (400
9
MHz, CDCl3) δ 7.43 – 7.36 (m, 2H), 7.25 – 7.06 (m, 5H), 5.43
(d, J = 1.6 Hz, 1H), 4.87 – 4.81 (m, 1H), 4.62 (m, 3H), 4.50 –
4.45 (m, 1H), 3.94 (d, J = 1.6 Hz, 2H), 3.48 (s, 2H), 2.35 (s,
3H), 1.79 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3) δ 148.2,
147.0, 139.1, 139.0, 138.2, 137.5, 137.4, 129.4, 129.4, 129.0,
128.1, 125.8, 113.3, 111.6, 59.0, 41.6, 38.4, 23.0, 21.1. IR
(neat) cm-13351, 3073, 2921, 2853, 1624, 1442, 1375, 1260,
1091, 995, 891; HRMS (ESI-TOF) m/z: (M+Na)+ calcd for
C21H24ONa 315.1719; found 315.1721.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
(2-(2-Methylallyl)-6-(2-(3-(prop-1-en-2-yl)phenyl)al-
lyl)phenyl)methanol (3h): Using the same procedure as that
used for 3a afforded 3h (25 mg, 79% yield) as a colorless
1
liquid. H NMR (400 MHz, CDCl3) δ 7.57 (t, J = 1.9 Hz, 1H),
7.43 – 7.38 (m, 2H), 7.31 (t, J = 7.6 Hz, 1H), 7.22 (t, J = 7.5 Hz,
1H), 7.15 (d, J = 7.9 Hz, 1H), 7.12 – 7.07 (m, 1H), 5.47 (s, 1H),
5.37 (s, 1H), 5.10 (t, J = 1.7 Hz, 1H), 4.85 (s, 1H), 4.70 (t, J =
1.6 Hz, 1H), 4.65 (d, J = 5.0 Hz, 2H), 4.48 (s, 1H), 3.98 (s, 2H),
3.49 (s, 2H), 2.16 (s, 3H), 1.80 (s, 3H). 13C{1H} NMR (100
MHz, CDCl3) δ 148.2, 146.6, 143.0, 141.0, 140.8, 138.7,
138.6, 137.0, 129.1, 129.0, 127.8, 127.8, 124.7, 124.5, 122.9,
113.8, 112.3, 111.3, 58.7, 41.3, 38.3, 22.6, 21.5. IR (neat) cm-
1 3349, 3073, 2921, 1628, 1593, 1441, 1375, 1247, 996, 891,
840; HRMS (ESI-TOF) m/z: (M+Na)+ calcd for C23H26ONa
341.1876; found 341.1884.
(2-(2-((Benzyloxy)methyl)allyl)-6-(2-methylallyl)phe-
nyl)methanol (3i): Using the same procedure as that used
for 3a afforded 3i (22 mg, 68% yield) as a colorless liquid.
1H NMR (400 MHz, CDCl3) δ 7.37 – 7.27 (m, 5H), 7.19 (t, J =
7.5 Hz, 1H), 7.08 (td, J = 7.9, 1.5 Hz, 2H), 5.12 (q, J = 1.4 Hz,
1H), 4.82 (d, J = 1.9 Hz, 2H), 4.62 (d, J = 5.2 Hz, 2H), 4.46 (s,
3H), 3.95 (s, 2H), 3.58(s, 2H), 3.58(s, 2H),1.77 (s, 3H).13C{1H}
NMR (100 MHz, CDCl3) δ 146.6, 146.4, 139.2, 138.3, 137.9,
137.6, 129.3, 129.0, 128.4, 128.0, 127.8, 127.7, 114.3, 111.6,
72.8, 71.8, 58.6, 41.5, 36.8, 23.0. IR (neat) cm-1 3405, 3068,
3028, 2910, 2852, 1648, 1588, 1448, 1373, 1067, 997, 894;
HRMS (ESI-TOF) m/z: (M+Na)+ calcd for C22H26O2Na
345.1825; found 345.1831.
(2-(2-((Benzylthio)methyl)allyl)-6-(2-methylallyl)phe-
nyl)methanol (3j): Using the same procedure as that used
for 3a afforded 3j (28 mg, 82% yield) as a colorless liquid.
1H NMR (400 MHz, CDCl3) δ 7.30 (m, 5H), 7.22 – 7.16 (m,
1H), 7.08 (d, J = 7.6 Hz, 2H), 4.95 (d, J = 1.3 Hz, 1H), 4.83 (t, J
= 1.6 Hz, 1H), 4.66 (d, J = 1.6 Hz, 1H), 4.64 (m, 4H), 4.46 (d, J
= 2.2 Hz, 1H), 3.66 (s, 2H), 3.64 (d, J = 1.4 Hz, 2H), 3.47 (s,
2H), 3.06 (s, 2H), 1.78 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3)
δ 146.8, 145.5, 139.2, 138.4, 138.1, 137.6, 129.4, 129.3,
129.0, 128.5, 128.1, 127.0, 114.7, 111.7, 58.8, 41.5, 37.7,
37.2, 35.4, 23.0. IR (neat) cm-1 3390, 3068, 3026, 2909,
1644, 1590, 1447, 1226, 1174, 1071, 994, 892; HRMS (ESI-
TOF) m/z: (M+Na)+ calcd for C22H26OSNa 361.1597; found
361.1599.
(2-Allyl-6-(2-(p-tolyl)allyl)phenyl)methanol (3m): Using
the same procedure as that used for 3a afforded 3m (16 mg,
58% yield) as a colorless liquid. 1H NMR (400 MHz, CDCl3) δ
7.40 (d, J = 8.2 Hz, 2H), 7.25 – 7.18 (m, 1H), 7.14 (m, 4H),
6.14 – 5.99 (m, 1H), 5.49 – 5.39 (m, 1H), 5.08 (dd, J = 10.1,
1.7 Hz, 1H), 4.98 (dd, J = 17.1, 1.8 Hz, 1H), 4.67 (d, J = 4.1 Hz,
2H), 4.65 – 4.60 (m, 1H), 3.94 (s, 2H), 3.64 – 3.50 (m, 3H),
2.36 (s, 3H). 13C{1H} NMR (150 MHz, CDCl3) δ 148.4, 139.4,
139.0, 138.4, 138.1, 137.5, 136.9, 129.3, 129.0, 128.8, 128.3,
125.7, 115.7, 113.3, 58.9, 38.5, 37.4, 37.4, 21.1. IR (neat) cm-
1
3339, 3076, 2854, 1636, 1598, 1513, 1464, 1405, 1276,
1176, 995, 905, 823, 750; HRMS (ESI-TOF) m/z: (M+Na)+
calcd for C20H22ONa 301.1563; found 301.1566.
(2-Allyl-6-cinnamylphenyl)methanol (3n): Using the same
procedure as that used for 3a afforded 3n (15 mg, 57%
yield) as a colorless liquid. 1H NMR (400 MHz, CDCl3) δ 7.48
– 7.04 (m, 8H), 6.54 – 6.27 (m, 2H), 6.19 – 5.99 (m, 1H), 5.04
(m, 2H), 4.75 (s, 2H), 3.71 (d, J = 5.1 Hz, 2H), 3.56 (d, J = 6.0
Hz, 2H). 13C{1H} NMR (100 MHz, CDCl3) δ 139.7, 139.4,
138.5, 137.3, 136.7, 130.8, 129.9, 128.7, 128.7, 128.5, 128.5,
127.2, 126.1, 115.7, 58.7, 37.5, 36.6. IR (neat) cm-1 3322,
2922, 1638, 1447, 1276, 913, 751; HRMS (ESI-TOF) m/z:
(M+Na)+ calcd for C19H20ONa 287.1406; found 287.1409.
(2-Allyl-6-(3-methylbut-2-en-1-yl)phenyl)methanol (3o):
Using the same procedure as that used for 3a afforded 3o
(12 mg, 56% yield) as a colorless liquid. 1H NMR (400 MHz,
CDCl3) δ 7.20 (t, J = 7.5 Hz, 1H), 7.09 (dd, J = 12.3, 7.5 Hz, 2H),
6.05 (ddt, J = 16.5, 10.2, 6.2 Hz, 1H), 5.26 (t, J = 6.9 Hz, 1H),
5.03 (ddd, J = 18.5, 13.6, 1.3 Hz, 2H), 3.54 (d, J = 6.1 Hz, 2H),
3.48 (d, J = 6.9 Hz, 2H), 1.76 (s, 3H), 1.73 (s, 3H). 13C{1H}
NMR (100 MHz, CDCl3) δ 141.6, 139.3, 138.5, 136.5, 132.5,
128.4, 128.2, 128.2, 123.9, 115.6, 58.7, 37.5, 32.2, 29.7, 25.7,
17.9; IR (neat) cm-1 3302, 2921, 1637, 1441, 1377, 996, 911;
HRMS (ESI-TOF) m/z: (M+Na)+ calcd for C15H20ONa
239.1406, found 239.1413.
Preparation of Intermediate 2b. (2-(Prop-1-en-2-yl)-6-
(trimethylsilyl)phenyl)methanol (2b): H NMR (400 MHz,
1
ACS Paragon Plus Environment